References

  1. Organisation Mondiale de la Santé (2012) Pour l'élimination de la transmission mère-enfant du VIH. http://applications.emro.who.int/dsaf/EMROPUB_2012_884_FR.pdf?. Consulté le 12 février 2013. Google Scholar

  2. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. Jama. 2001 Feb 14; 285(6):709-12. PubMed | Google Scholar

  3. Organisation Mondiale de la Santé (2005) La transmission du VIH par l'allaitement au sein: Bilan des connaissances actuelles. http://whqlibdoc.who.int/publications/2005/9242562718_fre.pdf?.Consulté le 12 février 2013. PubMed | Google Scholar

  4. Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, Harris DR, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004 Jun 15; 189(12):2154-66. PubMed | Google Scholar

  5. Leroy V, Karon JM, Alioum A, Ekpini ER, van de Perre P, Greenberg AE, et al. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa. Aids. 2003 Jul 4; 17(10):1493-501. PubMed | Google Scholar

  6. Faye A, Le Chenadec J, Dollfus C, Thuret I, Douard D, Firtion G, et al. Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis. 2004 Dec 1; 39(11):1692-8. PubMed | Google Scholar

  7. Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. Aids. 2009 Mar 13; 23(5):597-604. PubMed | Google Scholar

  8. Pignatelli S, Simpore J, Pietra V, Ouedraogo L, Conombo G, Saleri N, et al. Factors predicting uptake of voluntary counselling and testing in a real-life setting in a mother-and-child center in Ouagadougou, Burkina Faso. Trop Med Int Health. 2006 Mar; 11(3):350-7. PubMed | Google Scholar

  9. Simpore J, Pietra V, Savadogo A, Pignatelli S, Nikiema JB, Nadembega WM et al. Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. J Med Virol. 2006; 78 (2):148-152. PubMed | Google Scholar

  10. Simpore J, Pietra V, Pignatelli S, Karou D, Nadembega WM, Ilboudo D, et al. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. J Med Virol. 2007; 79(7):873-9. PubMed | Google Scholar

  11. Linguissi LS, Bisseye C, Sagna T, Nagalo BM, Ouermi D, Djigma FW, et al. Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa. Asian Pac J Trop Med. 2012 Dec; 5(12):991-4. PubMed | Google Scholar

  12. Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B, et al. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. AIDS Care. 2010 Jul; 22(7):843-50. PubMed | Google Scholar

  13. Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F, et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? Aids. 2005 Nov 4; 19(16):1865-75. PubMed | Google Scholar

  14. Shapiro RL, Ndung'u T, Lockman S, Smeaton LM, Thior I, Wester C, et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis. 2005 Sep 1; 192(5):713-9. PubMed | Google Scholar

  15. Hazen RJ, Harvey RJ, St Clair MH, Ferris RG, Freeman GA, Tidwell JH, et al. Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance. Antimicrob Agents Chemother. 2005; 49(11):4465-73. PubMed | Google Scholar

  16. Nadembega W M, Giannella S, Simpore J, Ceccherini-Silberstein F, Pietra V, Bertoli A, et al. Characterization of Drug-Resistance Mutations in HIV-1 Isolates From Non-HAART and HAART Treated Patients in Burkina Faso. J Med Virol. 2006; 78 (11): 1385-1391. PubMed | Google Scholar

  17. Bacheler L, Jeffrey S, Hanna G, D'Aquila R, Wallace L, Lougue K, et al. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing non-nucleoside reverse transcriptase inhibitor therapy. J Virol. 2001; 75(11):4999-5008. PubMed | Google Scholar

  18. Ferris RG, Hazen RJ, Roberts GB, St Clair MH, Chan JH, Romines KR, et al. Antiviral activity of GW678248, a novel benzophenome nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2005; 49(10):4046-51. PubMed | Google Scholar

  19. Arrive E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007 Oct; 36(5):1009-21. PubMed | Google Scholar

  20. Chaix ML, Ekouevi DK, Rouet F, Tonwe-Gold B, Viho I, Bequet L, et al. Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire. J Infect Dis. 2006 Feb 15; 193(4):482-7. PubMed | Google Scholar

  21. Chi BH, Sinkala M, Mbewe F, Cantrell RA, Kruse G, Chintu N, et al. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet. 2007 Nov 17; 370(9600):1698-705. PubMed | Google Scholar

  22. Organisation Mondiale de la Santé (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health appraoch. http://www.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?. Consulté le 20 juillet 2013. Google Scholar